[{"bbox": [92, 99, 368, 130], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [660, 171, 987, 199], "category": "Section-header", "text": "## BASIS FOR ISSUE PRICE"}, {"bbox": [90, 234, 1558, 361], "category": "Text", "text": "Investors should read the following summary with the section titled \"Risk Factors\", the details about our Company under the section titled \"Our Business\" and its financial statements under the section titled \"Financial Information of the Company\" beginning on page 29, 123 and 179 respectively of the Draft Red Herring Prospectus. The trading price of the Equity Shares of Our Company could decline due to these risks and the investor may lose all or part of his investment."}, {"bbox": [90, 393, 1560, 522], "category": "Text", "text": "Price Band/ Issue Price shall be determined by our Company in consultation with the Book Running Lead Managers on the basis of the assessment of market demand for the Equity Shares through the Book Building Process and on the basis of the qualitative and quantitative factors as described in this section. The face value of the Equity Shares is ₹10/- each and the Issue Price is [●] times of the face value at the lower end of the Price Band and [●] times of the face value at the upper end of the Price Band."}, {"bbox": [92, 553, 423, 584], "category": "Section-header", "text": "## QUALITATIVE FACTORS"}, {"bbox": [92, 617, 1128, 649], "category": "Text", "text": "We believe the following business strengths allow us to successfully compete in the industry:"}, {"bbox": [92, 681, 1322, 713], "category": "List-item", "text": "1. Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control."}, {"bbox": [92, 715, 824, 744], "category": "List-item", "text": "2. Diversified product portfolio with focus on IVD industry."}, {"bbox": [92, 746, 992, 776], "category": "List-item", "text": "3. Widespread distribution network with a presence across all four regions"}, {"bbox": [92, 778, 684, 808], "category": "List-item", "text": "4. Long standing relationships with customers."}, {"bbox": [92, 810, 706, 840], "category": "List-item", "text": "5. Track record of healthy financial performance"}, {"bbox": [92, 842, 706, 872], "category": "List-item", "text": "6. Experienced Promoter and Management team"}, {"bbox": [92, 905, 1558, 969], "category": "Text", "text": "For a detailed discussion on the qualitative factors which form the basis for computing the price, please refer to sections titled \"Our Business\" beginning on page 123 of this Draft Red Herring Prospectus."}, {"bbox": [92, 1001, 444, 1032], "category": "Section-header", "text": "## QUANTITATIVE FACTORS"}, {"bbox": [92, 1065, 1558, 1128], "category": "Text", "text": "The information presented below relating to our Company is based on the Restated Financial Statements. For details, please refer section titled \"Financial Information of the Company\" on page 179 of this Draft Red Herring Prospectus."}, {"bbox": [92, 1160, 1245, 1191], "category": "Text", "text": "Some of the quantitative factors which may form the basis for calculating the Issue Price are as follows:"}, {"bbox": [117, 1224, 971, 1256], "category": "Section-header", "text": "### 1. Basic & Diluted Earnings per share (EPS) (Face value of ₹ 10 each):"}, {"bbox": [92, 1288, 719, 1318], "category": "Text", "text": "As per the Consolidated Restated Financial Statements:-"}, {"bbox": [92, 1348, 1558, 1518], "category": "Table", "text": "<table><thead><tr><td>Sr. No</td><td>F.Y./Period</td><td>Basic & Diluted (₹)</td><td>Weights</td></tr></thead><tbody><tr><td>1.</td><td>Financial Year ending March 31, 2025</td><td>28.63</td><td>3</td></tr><tr><td>2.</td><td>Financial Year ending March 31, 2024</td><td>21.87</td><td>2</td></tr><tr><td>3.</td><td>Financial Year ending March 31, 2023</td><td>20.38</td><td>1</td></tr><tr><td colspan=\"2\">Weighted Average</td><td>25.00</td><td></td></tr></tbody></table>"}, {"bbox": [92, 1554, 168, 1580], "category": "Section-header", "text": "**Notes:**"}, {"bbox": [117, 1585, 1196, 1616], "category": "List-item", "text": "i. The figures disclosed above are based on the Restated Financial Statements of the Company."}, {"bbox": [117, 1618, 684, 1647], "category": "List-item", "text": "ii. The face value of each Equity Share is ₹10.00."}, {"bbox": [117, 1649, 1558, 1710], "category": "List-item", "text": "iii. Earnings per Share has been calculated in accordance with Accounting Standard 20 – \"Earnings per Share\" issued by the Institute of Chartered Accountants of India."}, {"bbox": [117, 1712, 1558, 1775], "category": "List-item", "text": "iv. The above statement should be read with Significant Accounting Policies and the Notes to the Restated Financial Statements as appearing in Annexure IV."}, {"bbox": [117, 1777, 1558, 1839], "category": "List-item", "text": "v. Basic Earnings per Share = Net Profit/(Loss) after tax, as restated attributable to equity shareholders / Weighted average number of equity shares outstanding during the year/ period"}, {"bbox": [117, 1841, 1558, 1904], "category": "List-item", "text": "vi. Diluted Earnings per Share = Net Profit/(Loss) after tax, as restated attributable to equity shareholders / Weighted average number of diluted potential equity shares outstanding during the year/ period."}, {"bbox": [117, 1937, 1558, 2000], "category": "Section-header", "text": "### 2. Price Earning (P/E) Ratio in relation to the Price Band of ₹[●] to ₹[●] per Equity Share of Face Value of ₹10/- each fully paid up"}, {"bbox": [92, 2028, 1558, 2161], "category": "Table", "text": "<table><thead><tr><td>Particulars</td><td>(P/E) Ratio at the Floor Price</td><td>(P/E) Ratio at the Cap Price</td></tr></thead><tbody><tr><td>P/E ratio based on the Basic & Diluted EPS, as restated for the period ending March 31, 2024</td><td>[●]</td><td>[●]</td></tr></tbody></table>"}, {"bbox": [810, 2172, 840, 2199], "category": "Page-footer", "text": "94"}]